Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (8234)	9/17/2000 4:05:58 PM
From: Biotech Jim	Read Replies (1) \| Respond to of 9719

Regarding an entry price for LEXG, I see an initial entry in the 25 to 30 area, hopefully. With a total of 40M shares and a 10M float, LEXG may be a stock that will continue accumulation for a while. Good science and a very good balance sheet. Don't know all the details of the business plan, though. Nonetheless, at a $2B market cap currently, it is a bit pricey for me. I'm a bit surprised that DGEN is 1/3 the market value of LEXG. Jim